Clik here to view.
PHCホールディングス株式会社: 社名変更のお知らせ
東京 （ビジネスワイヤ） – PHCホールディングス株式会社（本社：東京都港区）は、2018年4月1日付けでパナソニック ヘルスケアホールディングス株式会社より、社名変更しましたのでお知らせいたします。 ●新社名（商号） 和文社名 PHCホールディングス株式会社 英文社名 PHC Holdings Corporation...
View ArticleClik here to view.
サンバイオ：再生細胞薬「SB623」の開発進捗総括の更新について
東京 （ビジネスワイヤ） — 平成30年３月13日付リリース『再生細胞薬「SB623」の開発進捗総括の更新について』に記載した「SB623」の開発の進捗に動きがあり、これに伴い一部の内容を更新しました。更新箇所は下線の部分であります。 記...
View ArticleClik here to view.
SanBio: Update on Development Progress of Regenerative Cell Medicine SB623
TOKYO The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.) (TOKYO:4592) has updated part of its March 13, 2018 release “Update on Development Progress of Regenerative Cell Medicine SB623”....
View ArticleClik here to view.
PharmAbcine宣布，FDA向用于多形性胶质母细胞瘤的TTAC-0001签发孤儿药认证
韩国大田 (美国商业资讯) — PharmAbcine Inc.是一家临床阶段生物技术公司，开发用于多种癌症适应证的新型抗体治疗药物，该公司今天宣布，美国食品药品管理局(FDA)已向该公司用于“治疗多形性胶质母细胞瘤”的领先临床化合物TTAC-0001签发了孤儿药认证。 PharmAbcine, Inc.总裁兼首席执行官Jin-San...
View ArticleClik here to view.
Cullgen Announces ALK PROTACs Publication by Its Co-founders in the European...
DOVER, Del. Cullgen Inc., a biopharmaceutical company focusing on developing new drugs using protein degradation technology today announced that the laboratories of its co-founders, Dr. Jian Jin and...
View ArticleClik here to view.
AVITA Medical Announces Schedule for Six RECELL® Device Presentations at...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today new data to be presented describing clinical and cost-savings advantages of RECELL® Device in the...
View ArticleClik here to view.
ファーマブシン、FDAが多形性膠芽腫治療薬TTAC-0001を希少疾病用医薬品に指定したと発表
韓国・テジョン （ビジネスワイヤ） — 複数のがん適応症に対する新規抗体医薬品の開発に当たっている臨床開発段階のバイオテクノロジー企業ファーマブシンは、米国食品医薬品局（FDA）が「多形性膠芽腫治療」のための当社の有力臨床化合物TTAC-0001を希少疾病用医薬品に指定したと発表しました。 ファーマブシンの社長兼最高経営責任者（CEO）であるJin-San...
View ArticleClik here to view.
Mevion下一代质子治疗系统治疗首例患者
马萨诸塞州利特尔顿 (美国商业资讯) — Mevion Medical Systems宣布，华盛顿特区MedStar乔治敦大学医院在全球率先采用MEVION S250i质子治疗系统®治疗患者。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20180403005749/zh-CN/ The MEVION S250i...
View ArticleClik here to view.
Terns Pharmaceuticals获得礼来公司(Eli Lilly and Company)三项NASH资产的全球独家开发和商业化权益
加州圣马特奥 (美国商业资讯) — Terns Pharmaceuticals...
View ArticleClik here to view.
Terns Pharmaceuticals Acquires Global, Exclusive Rights to Develop and...
SAN MATEO, Calif. Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly targeted, oral, small molecule drugs to treat liver disease and...
View ArticleClik here to view.
Samsung Bioepis Settles Patent Disputes with AbbVie, Clearing the Way for the...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that it has signed a licensing agreement with AbbVie Inc., settling all pending patent litigation between the two companies and clearing the...
View ArticleClik here to view.
Anika Announces Plans to Showcase HYALOFAST Hyaluronic Acid-Based Scaffold at...
BEDFORD, Mass. Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
View ArticleClik here to view.
NZMP: New Research Hopes to Unlock Understanding of How the Gut and Brain...
LONDON NZMP SureStart™, the global B2B paediatric ingredients brand of Fonterra, announces today it is part of Smarter Lives, a five-year research programme to investigate how nutrition impacts the...
View ArticleClik here to view.
HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International...
SOUTHLAKE, Texas HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 China International Medicinal Equipment Fair (CMEF)...
View ArticleClik here to view.
PAREXEL and Meiji Pharmaceutical University Announce Academic Program to...
BOSTON & TOKYO PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, and Meiji Pharmaceutical University (MPU), a private pharmacy and science...
View ArticleClik here to view.
Sonde Health Announces U.S. and Australian Patent Issuances Broadly Covering...
BOSTON Sonde Health Inc., an affiliate of PureTech Health (PureTech Health plc, PRTC.L) developing a voice-based technology platform for monitoring and diagnosing mental and physical medical...
View ArticleClik here to view.
FIMECS, Inc. Concludes Licensing Agreement with Takeda to Develop Novel...
KANAGAWA, Japan FIMECS, Inc. (“FIMECS”), a private biotechnology company creating a new class of drugs based on protein degradation, today announced it has concluded a strategic licensing agreement...
View ArticleClik here to view.
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize...
TOKYO Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced the company will partner with Mylan N.V. (NASDAQ:MYL) to commercialize FKB327, a biosimilar to Humira® (adalimumab) developed by...
View ArticleClik here to view.
Selexis SA Strengthens Cell Line Development Services for Partners with Key...
GENEVA Selexis SA today announced it has made key strategic hires, signed its one hundredth commercial license agreement (CLA) and purchased and installed $2 million in new laboratory equipment...
View ArticleClik here to view.
JPT Peptide Technologies发布人类蛋白质组肽目录
柏林 (美国商业资讯) — JPT Peptide Technologies (JPT)宣布发布人类蛋白质组肽目录，这是质谱蛋白质组学领域首个也是最全面的经过验证的参照肽在线资源。 这个新的存储库可快速调阅40多万种轻重蛋白质型肽，基本涵盖人体所有蛋白质。目前，该肽数据集可匹配合计19,840种蛋白质，并可通过ProteomicsDB数据库中逾1000万个经过验证的图谱进行证实。...
View Article